“Asia continues to play an increasingly important role in advancing innovation across the global biopharma industry,” said Daniella Cramp, Senior Vice President and President, BioProduction at Thermo Fisher Scientific. &ld... Read more
In these diverse and dynamic markets, adaptation is not a strategy; it is a prerequisite for thriving. Success requires a fundamental shift in mindset: walking away is rarely an option, and profitability depends on establishing a hyper-agile ... Read more
Net sales increase organically by +5.2% to € 5.3 billion; foreign exchange effects of –4.9%, portfolio effects of +0.7% EBITDA pre grows organically by +8.8% to € 1.7 billion; foreign exchange effects of... Read more
Reports third quarter 2025 total revenue of $7.8 million, representing 3% growth compared to the third quarter of 2024. Third quarter 2025 recurring revenue, which includes consumables and annual service contracts, increased 32% compared ... Read more
Bavarian Nordic A/S announced its intent to launch a one-time share buy-back program of up to DKK 500 million to be executed over the next 12 months. This decision should be viewed in the context of a current strong cash position, resulting ... Read more
-Merck (NYSE: MRK), known as MSD outside the United States and Canada, has been notified that Tutanota LLC (Tutanota) has commenced an unsolicited “mini-tender” offer, dated November 10, 2025, to purchase up to 1,000,000 shares of Merck... Read more
Cell therapy manufacturers Charles River and ElevateBio are named as inaugural members Akadeum Life Sciences, the leader in buoyant cell separation, announces the establishment of the Akadeum CDMO Alliance™ and the first two members in the c... Read more
Tjoapack, a leading global contract packaging organization, has announced a significant strategic investment to expand its operational footprint in the U.S., strengthening its position as a trusted partner in pharmaceutical supply chain solutions. T... Read more
© 2025 Biopharma Boardroom. All Rights Reserved.
